ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 82 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18 | -99.8% | 34,141 | +134.6% | 0.00% | – |
| Q3 2022 | $11,000 | -45.0% | 14,553 | -18.8% | 0.00% | – |
| Q2 2022 | $20,000 | -60.8% | 17,929 | -27.5% | 0.00% | -100.0% |
| Q1 2022 | $51,000 | -62.8% | 24,725 | -48.1% | 0.00% | 0.0% |
| Q4 2021 | $137,000 | +38.4% | 47,659 | +103.1% | 0.00% | 0.0% |
| Q3 2021 | $99,000 | -57.7% | 23,466 | -46.8% | 0.00% | -66.7% |
| Q2 2021 | $234,000 | +178.6% | 44,147 | +144.6% | 0.00% | +200.0% |
| Q1 2021 | $84,000 | -85.0% | 18,047 | -89.1% | 0.00% | -93.3% |
| Q2 2020 | $559,000 | +598.8% | 165,731 | +1147.0% | 0.02% | +650.0% |
| Q4 2019 | $80,000 | – | 13,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,447,407 | $2,815,000 | 0.08% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 224,221 | $256,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 132,405 | $151,000 | 0.02% |
| Bernardo Wealth Planning LLC | 30,469 | $34,000 | 0.02% |
| Penserra Capital Management LLC | 349,336 | $398,000 | 0.01% |
| Key FInancial Inc | 7,500 | $9,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $57,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 165,900 | $189,000 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 1,232,456 | $1,405,000 | 0.00% |
| King Wealth Management Group | 16,000 | $18,000 | 0.00% |